Thiostrepton

硫链丝菌素

Report date: 2025/12/25 15:59:34
NME

Base Information

Drug NameThiostrepton
Drug Alias NametiostreptonRSO-021
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionPeroxiredoxin 3 inhibitors
TargetsPeroxiredoxin 3
Therapy Area/IndicationsSolid tumoursPleural Effusion, MalignantMesothelioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRS Oncology LLC
China Registration ClassN/A

Develop Information

Active CompaniesRS Oncology LLC
Inactive CompaniesN/A
Active IndicationsSolid tumoursPleural Effusion, MalignantMesothelioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A